Persistence of Integrase-Deficient Lentiviral Vectors Correlates with the Induction of STING-Independent CD8 T Cell Responses
Overview
Cell Biology
Molecular Biology
Authors
Affiliations
Lentiviruses are among the most promising viral vectors for in vivo gene delivery. To overcome the risk of insertional mutagenesis, integrase-deficient lentiviral vectors (IDLVs) have been developed. We show here that strong and persistent specific cytotoxic T cell (CTL) responses are induced by IDLVs, which persist several months after a single injection. These responses were associated with the induction of mild and transient maturation of dendritic cells (DCs) and with the production of low levels of inflammatory cytokines and chemokines. They were independent of the IFN-I, TLR/MyD88, interferon regulatory factor (IRF), retinoic acid induced gene I (RIG-I), and stimulator of interferon genes (STING) pathways but require NF-κB signaling in CD11c DCs. Despite the lack of integration of IDLVs, the transgene persists for 3 months in the spleen and liver of IDLV-injected mice. These results demonstrate that the capacity of IDLVs to trigger persistent adaptive responses is mediated by a weak and transient innate response, along with the persistence of the vector in tissues.
CRISPR technology in human diseases.
Feng Q, Li Q, Zhou H, Wang Z, Lin C, Jiang Z MedComm (2020). 2024; 5(8):e672.
PMID: 39081515 PMC: 11286548. DOI: 10.1002/mco2.672.
T-cell immunity induced and reshaped by an anti-HPV immuno-oncotherapeutic lentiviral vector.
Fert I, Douguet L, Vesin B, Moncoq F, Noirat A, Authie P NPJ Vaccines. 2024; 9(1):102.
PMID: 38858404 PMC: 11164992. DOI: 10.1038/s41541-024-00894-0.
Emerging mechanisms and implications of cGAS-STING signaling in cancer immunotherapy strategies.
Zhang J, Yu S, Peng Q, Wang P, Fang L Cancer Biol Med. 2024; 21(1).
PMID: 38172538 PMC: 10875285. DOI: 10.20892/j.issn.2095-3941.2023.0440.
Wu Q, Xia Y, Xiong X, Duan X, Pang X, Zhang F Front Pharmacol. 2023; 14:1169608.
PMID: 37180717 PMC: 10173311. DOI: 10.3389/fphar.2023.1169608.
Lentiviral Vectors as a Vaccine Platform against Infectious Diseases.
Nemirov K, Bourgine M, Anna F, Wei Y, Charneau P, Majlessi L Pharmaceutics. 2023; 15(3).
PMID: 36986707 PMC: 10053212. DOI: 10.3390/pharmaceutics15030846.